Jason I. Herschkowitz

Baylor College of Medicine — United States

Medicine · Health Sciences

32h-index9.7kcitations150works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(38), Cancer-related Molecular Pathways(32), Fibroblast Growth Factor Research(31), Cancer-related molecular mechanisms research(29), RNA modifications and cancer(29)

Publications150 total

Data from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 2 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 5 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure Legend from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure 3 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 3 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 4 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure 1 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 2 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure 2 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Data from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 1 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure 3 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 5 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 1 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 4 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Table 3 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure 1 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure 2 from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
Supplementary Figure Legend from Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Charles M. Perou(20), Jeffrey M. Rosen(16), Rebecca Sinnott(8), Xiaping He(6), Jerry Usary(6), Cheng Fan(5), Melissa A. Troester(5), Aleix Prat(4), Victor Weigman(4), Olga Karginova(3), Susan G. Hilsenbeck(3), Michael T. Lewis(3), Joseph H. Taube(3), Sendurai A. Mani(3), Thomas F. Westbrook(3), Adam D. Pfefferle(3), Adam C. Pond(3), Tuan M. Nguyen(3), Stephanie Greene(3), Katherine A. Hoadley(3)